Artiva Biotherapeutics, Inc. business relationships
Companies named in Artiva Biotherapeutics, Inc.’s 10-K filed 2026-03-10, and public companies whose annual reports name Artiva Biotherapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.7 / 10
- AI naming
- 4 / 100 Top 3% in its category
- Agent readiness
- 40 / 100
- AI adoption
- 0 / 100
Named in Artiva Biotherapeutics, Inc.’s annual report 2
“Amendment No. 1 to Option and License Agreement, dated June 23, 2020, by and between the Registrant and GC Cell Corporation.” SEC filing
“Our collaboration agreements with GC Cell Corporation (GC Cell) and any future collaborations with third parties to develop or commercialize our product candidates, mean that our prospects with respect to the product candidates involved will depend in significant part on the success of those collabo...” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.